Highlights

[PHARMA] QoQ Quarter Result on 2013-09-30 [#3]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 19-Nov-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 30-Sep-2013  [#3]
Profit Trend QoQ -     -36.04%    YoY -     -85.14%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 525,072 468,672 567,860 440,807 437,633 500,339 482,404 5.83%
  QoQ % 12.03% -17.47% 28.82% 0.73% -12.53% 3.72% -
  Horiz. % 108.84% 97.15% 117.71% 91.38% 90.72% 103.72% 100.00%
PBT 24,622 38,159 33,007 13,461 9,605 36,924 4,248 223.71%
  QoQ % -35.48% 15.61% 145.20% 40.15% -73.99% 769.21% -
  Horiz. % 579.61% 898.28% 777.00% 316.88% 226.11% 869.21% 100.00%
Tax -8,665 -11,513 -11,740 -9,291 -3,434 -11,771 -11,716 -18.26%
  QoQ % 24.74% 1.93% -26.36% -170.56% 70.83% -0.47% -
  Horiz. % 73.96% 98.27% 100.20% 79.30% 29.31% 100.47% 100.00%
NP 15,957 26,646 21,267 4,170 6,171 25,153 -7,468 -
  QoQ % -40.11% 25.29% 410.00% -32.43% -75.47% 436.81% -
  Horiz. % -213.67% -356.80% -284.78% -55.84% -82.63% -336.81% 100.00%
NP to SH 15,975 26,217 20,813 3,751 5,865 24,771 -7,934 -
  QoQ % -39.07% 25.96% 454.87% -36.04% -76.32% 412.21% -
  Horiz. % -201.35% -330.44% -262.33% -47.28% -73.92% -312.21% 100.00%
Tax Rate 35.19 % 30.17 % 35.57 % 69.02 % 35.75 % 31.88 % 275.80 % -74.75%
  QoQ % 16.64% -15.18% -48.46% 93.06% 12.14% -88.44% -
  Horiz. % 12.76% 10.94% 12.90% 25.03% 12.96% 11.56% 100.00%
Total Cost 509,115 442,026 546,593 436,637 431,462 475,186 489,872 2.61%
  QoQ % 15.18% -19.13% 25.18% 1.20% -9.20% -3.00% -
  Horiz. % 103.93% 90.23% 111.58% 89.13% 88.08% 97.00% 100.00%
Net Worth 502,293 515,022 486,672 473,402 480,568 484,829 472,037 4.24%
  QoQ % -2.47% 5.83% 2.80% -1.49% -0.88% 2.71% -
  Horiz. % 106.41% 109.11% 103.10% 100.29% 101.81% 102.71% 100.00%
Dividend
30/06/20 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/19 CAGR
Div 10,356 10,352 16,049 7,760 8,810 8,825 11,771 -8.20%
  QoQ % 0.04% -35.50% 106.81% -11.91% -0.17% -25.02% -
  Horiz. % 87.98% 87.94% 136.34% 65.93% 74.85% 74.98% 100.00%
Div Payout % 64.83 % 39.49 % 77.11 % 206.90 % 150.22 % 35.63 % - % -
  QoQ % 64.17% -48.79% -62.73% 37.73% 321.61% 0.00% -
  Horiz. % 181.95% 110.83% 216.42% 580.69% 421.61% 100.00% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 502,293 515,022 486,672 473,402 480,568 484,829 472,037 4.24%
  QoQ % -2.47% 5.83% 2.80% -1.49% -0.88% 2.71% -
  Horiz. % 106.41% 109.11% 103.10% 100.29% 101.81% 102.71% 100.00%
NOSH 258,914 258,805 258,868 258,689 258,370 117,676 117,715 69.37%
  QoQ % 0.04% -0.02% 0.07% 0.12% 119.56% -0.03% -
  Horiz. % 219.95% 219.86% 219.91% 219.76% 219.49% 99.97% 100.00%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 3.04 % 5.69 % 3.75 % 0.95 % 1.41 % 5.03 % -1.55 % -
  QoQ % -46.57% 51.73% 294.74% -32.62% -71.97% 424.52% -
  Horiz. % -196.13% -367.10% -241.94% -61.29% -90.97% -324.52% 100.00%
ROE 3.18 % 5.09 % 4.28 % 0.79 % 1.22 % 5.11 % -1.68 % -
  QoQ % -37.52% 18.93% 441.77% -35.25% -76.13% 404.17% -
  Horiz. % -189.29% -302.98% -254.76% -47.02% -72.62% -304.17% 100.00%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 202.80 181.09 219.36 170.40 169.38 425.18 409.81 -37.52%
  QoQ % 11.99% -17.45% 28.73% 0.60% -60.16% 3.75% -
  Horiz. % 49.49% 44.19% 53.53% 41.58% 41.33% 103.75% 100.00%
EPS 6.17 10.13 8.04 1.45 2.27 21.05 -6.74 -
  QoQ % -39.09% 26.00% 454.48% -36.12% -89.22% 412.31% -
  Horiz. % -91.54% -150.30% -119.29% -21.51% -33.68% -312.31% 100.00%
DPS 4.00 4.00 6.20 3.00 3.41 7.50 10.00 -45.80%
  QoQ % 0.00% -35.48% 106.67% -12.02% -54.53% -25.00% -
  Horiz. % 40.00% 40.00% 62.00% 30.00% 34.10% 75.00% 100.00%
NAPS 1.9400 1.9900 1.8800 1.8300 1.8600 4.1200 4.0100 -38.45%
  QoQ % -2.51% 5.85% 2.73% -1.61% -54.85% 2.74% -
  Horiz. % 48.38% 49.63% 46.88% 45.64% 46.38% 102.74% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 201.00 179.41 217.38 168.74 167.53 191.53 184.67 5.83%
  QoQ % 12.03% -17.47% 28.83% 0.72% -12.53% 3.71% -
  Horiz. % 108.84% 97.15% 117.71% 91.37% 90.72% 103.71% 100.00%
EPS 6.12 10.04 7.97 1.44 2.25 9.48 -3.04 -
  QoQ % -39.04% 25.97% 453.47% -36.00% -76.27% 411.84% -
  Horiz. % -201.32% -330.26% -262.17% -47.37% -74.01% -311.84% 100.00%
DPS 3.96 3.96 6.14 2.97 3.37 3.38 4.51 -8.33%
  QoQ % 0.00% -35.50% 106.73% -11.87% -0.30% -25.06% -
  Horiz. % 87.80% 87.80% 136.14% 65.85% 74.72% 74.94% 100.00%
NAPS 1.9228 1.9715 1.8630 1.8122 1.8396 1.8559 1.8070 4.24%
  QoQ % -2.47% 5.82% 2.80% -1.49% -0.88% 2.71% -
  Horiz. % 106.41% 109.10% 103.10% 100.29% 101.80% 102.71% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 4.6100 4.4600 4.4500 4.8200 4.4900 8.2600 8.1000 -
P/RPS 2.27 2.46 2.03 2.83 2.65 1.94 1.98 9.57%
  QoQ % -7.72% 21.18% -28.27% 6.79% 36.60% -2.02% -
  Horiz. % 114.65% 124.24% 102.53% 142.93% 133.84% 97.98% 100.00%
P/EPS 74.72 44.03 55.35 332.41 197.80 39.24 -120.18 -
  QoQ % 69.70% -20.45% -83.35% 68.05% 404.08% 132.65% -
  Horiz. % -62.17% -36.64% -46.06% -276.59% -164.59% -32.65% 100.00%
EY 1.34 2.27 1.81 0.30 0.51 2.55 -0.83 -
  QoQ % -40.97% 25.41% 503.33% -41.18% -80.00% 407.23% -
  Horiz. % -161.45% -273.49% -218.07% -36.14% -61.45% -307.23% 100.00%
DY 0.87 0.90 1.39 0.62 0.76 0.91 1.23 -20.66%
  QoQ % -3.33% -35.25% 124.19% -18.42% -16.48% -26.02% -
  Horiz. % 70.73% 73.17% 113.01% 50.41% 61.79% 73.98% 100.00%
P/NAPS 2.38 2.24 2.37 2.63 2.41 2.00 2.02 11.59%
  QoQ % 6.25% -5.49% -9.89% 9.13% 20.50% -0.99% -
  Horiz. % 117.82% 110.89% 117.33% 130.20% 119.31% 99.01% 100.00%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 -
Price 4.6200 4.7000 4.2900 4.7200 4.6600 9.2600 7.8000 -
P/RPS 2.28 2.60 1.96 2.77 2.75 2.18 1.90 12.96%
  QoQ % -12.31% 32.65% -29.24% 0.73% 26.15% 14.74% -
  Horiz. % 120.00% 136.84% 103.16% 145.79% 144.74% 114.74% 100.00%
P/EPS 74.88 46.40 53.36 325.52 205.29 43.99 -115.73 -
  QoQ % 61.38% -13.04% -83.61% 58.57% 366.67% 138.01% -
  Horiz. % -64.70% -40.09% -46.11% -281.28% -177.39% -38.01% 100.00%
EY 1.34 2.16 1.87 0.31 0.49 2.27 -0.86 -
  QoQ % -37.96% 15.51% 503.23% -36.73% -78.41% 363.95% -
  Horiz. % -155.81% -251.16% -217.44% -36.05% -56.98% -263.95% 100.00%
DY 0.87 0.85 1.45 0.64 0.73 0.81 1.28 -22.75%
  QoQ % 2.35% -41.38% 126.56% -12.33% -9.88% -36.72% -
  Horiz. % 67.97% 66.41% 113.28% 50.00% 57.03% 63.28% 100.00%
P/NAPS 2.38 2.36 2.28 2.58 2.51 2.25 1.95 14.25%
  QoQ % 0.85% 3.51% -11.63% 2.79% 11.56% 15.38% -
  Horiz. % 122.05% 121.03% 116.92% 132.31% 128.72% 115.38% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

292  614  561  984 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.13-0.27 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.96-0.04 
 HWGB 0.78+0.065 
 DGSB 0.225+0.01 
 DATAPRP 0.195-0.025 
 KSTAR 0.43+0.06 
 MTOUCHE 0.045-0.01 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS